…
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
U.S. Physical Therapy, Inc. operates a network of outpatient physical therapy clinics across the United States, providing rehabilitation services for musculoskeletal and related conditions. Long-term growth drivers include an aging population, greater use of outpatient rehabilitation, and expansion via new clinic openings and acquisitions, which may benefit revenue growth and scale. The company appears positioned to generate recurring cash flow from fee-for-service care and contract arrangements with payers and employers.
Key risks include reimbursement and regulatory pressure from Medicare and private payers, intense competition and execution risk associated with clinic expansion and acquisitions, and sensitivity to labor costs and utilization trends that investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 55.57M | 73.20M | 65.51M | 70.91M | 60.21M |
| Minority interest | -11.25M | -17.09M | 17.30M | 17.22M | 13.97M |
| Net income | 43.41M | 57.92M | 52.49M | 57.26M | 10.10M |
| Selling general administrative | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M |
| Gross profit | 112.02M | 117.18M | 94.45M | 112.47M | 101.66M |
| Reconciled depreciation | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M |
| Ebit | 56.80M | 76.77M | 52.41M | 67.42M | 60.41M |
| Ebitda | 82.69M | 88.36M | 76.59M | 83.08M | 70.16M |
| Depreciation and amortization | 25.89M | 11.59M | 24.18M | 15.65M | 9.76M |
| Non operating income net other | - | 2.55M | 13.10M | 0.05M | 1.94M |
| Operating income | 56.80M | 76.77M | 52.41M | 67.42M | 60.31M |
| Other operating expenses | 487.23M | 419.78M | 357.06M | 414.54M | 393.60M |
| Interest expense | 5.78M | 0.94M | 1.63M | 2.08M | 2.04M |
| Tax provision | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M |
| Interest income | 0.86M | 0.20M | 0.14M | 0.05M | 0.09M |
| Net interest income | -4.92M | -0.74M | -1.49M | -2.03M | -1.95M |
| Income tax expense | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M |
| Total revenue | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M |
| Total operating expenses | 46.11M | 41.94M | 28.54M | 45.05M | 41.35M |
| Cost of revenue | 441.12M | 377.84M | 328.52M | 369.50M | 352.25M |
| Total other income expense net | -1.23M | -3.58M | 13.10M | 3.48M | 1.85M |
| Net income from continuing ops | 43.41M | 57.92M | 52.49M | 57.26M | 48.84M |
| Net income applicable to common shares | 29.26M | 40.83M | 35.19M | 40.04M | 34.87M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 858.15M | 749.43M | 594.36M | 560.85M | 443.17M |
| Intangible assets | 108.75M | 86.38M | 56.28M | 52.59M | 48.83M |
| Other current assets | 11.07M | 4.18M | 3.77M | 5.79M | 4.35M |
| Total liab | 373.59M | 296.98M | 184.39M | 181.39M | 92.35M |
| Total stockholder equity | 315.79M | 295.61M | 276.16M | 240.26M | 215.94M |
| Deferred long term liab | - | - | - | - | 2.16M |
| Other current liab | 37.41M | 45.70M | 59.75M | 30.86M | 38.49M |
| Common stock | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M |
| Capital stock | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M |
| Retained earnings | 232.95M | 223.57M | 212.01M | 184.35M | 167.40M |
| Other liab | 34.33M | 21.73M | 12.32M | 10.21M | 12.00M |
| Good will | 494.10M | 434.68M | 345.65M | 317.68M | 293.52M |
| Other assets | 1.63M | 1.58M | 14.05M | 1.52M | 1.43M |
| Cash | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M |
| Total current liabilities | 85.49M | 83.48M | 93.49M | 60.56M | 41.95M |
| Net debt | 263.74M | 194.51M | 78.07M | 114.28M | 16.47M |
| Short term debt | 41.57M | 31.30M | 32.41M | 27.21M | 1.43M |
| Short long term debt | 7.86M | 0.83M | 4.90M | 0.73M | 1.43M |
| Short long term debt total | 295.34M | 223.08M | 110.99M | 137.83M | 39.84M |
| Other stockholder equity | 78.69M | 71.88M | 63.99M | 55.76M | 112.55M |
| Property plant equipment | 127.75M | 119.41M | 21.66M | 22.09M | 20.17M |
| Total current assets | 111.27M | 95.17M | 87.64M | 85.39M | 79.21M |
| Long term investments | 12.13M | 12.21M | - | - | - |
| Net tangible assets | -287.06M | -225.46M | 6.57M | 7.74M | 7.54M |
| Net receivables | 68.61M | 62.42M | 50.95M | 56.05M | 51.49M |
| Long term debt | 175.83M | 117.59M | 16.60M | 50.36M | 38.40M |
| Accounts payable | 6.50M | 6.47M | 1.33M | 2.49M | 2.02M |
| Noncontrolling interest in consolidated entity | - | 1.57M | 1.47M | 1.44M | 0.93M |
| Accumulated other comprehensive income | 4.00M | -0.40M | - | -66.10M | -64.15M |
| Common stock total equity | - | 0.15M | 0.15M | 0.15M | 0.15M |
| Retained earnings total equity | - | 224.40M | 212.01M | 184.35M | 167.40M |
| Treasury stock | - | -31.63M | -31.63M | -31.63M | -31.63M |
| Non currrent assets other | 4.15M | 1.58M | 1.54M | 1.52M | 1.43M |
| Non current assets total | 746.89M | 654.26M | 506.73M | 475.46M | 363.95M |
| Capital lease obligations | 111.64M | 104.66M | 89.50M | 86.74M | - |
| Long term debt total | - | 117.59M | 16.60M | 50.36M | 38.40M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -81.27M | 0.43M | -0.11M | -0.22M | -23.91M |
| Change to liabilities | -7.75M | 4.66M | 16.92M | -5.23M | 4.91M |
| Total cashflows from investing activities | -81.27M | -124.14M | -51.20M | -37.99M | -23.91M |
| Net borrowings | 64.19M | 93.10M | -31.04M | 6.57M | -20.04M |
| Total cash from financing activities | 25.76M | 43.38M | -39.42M | -24.27M | -47.66M |
| Change to operating activities | -3.40M | -6.96M | 10.31M | -5.40M | -0.71M |
| Net income | 43.41M | 57.92M | 52.49M | 57.26M | 48.84M |
| Change in cash | 3.03M | -4.35M | 9.37M | 0.18M | 1.44M |
| Begin period cash flow | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M |
| End period cash flow | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M |
| Total cash from operating activities | 58.54M | 76.41M | 100.00M | 62.45M | 73.00M |
| Depreciation | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M |
| Other cashflows from investing activities | - | -114.73M | -43.45M | -27.58M | -16.72M |
| Dividends paid | -21.32M | -18.77M | -4.11M | -14.55M | 11.66M |
| Change to inventory | - | -4.66M | -12.43M | 4.21M | -0.74M |
| Change to account receivables | -10.28M | -9.42M | 0.90M | -6.38M | -3.43M |
| Sale purchase of stock | - | 0.91M | - | 0.50M | -0.27M |
| Other cashflows from financing activities | 233.88M | 285.04M | 209.72M | 128.71M | 87.05M |
| Change to netincome | 33.07M | 35.71M | 14.42M | 16.59M | 13.68M |
| Capital expenditures | 8.25M | 8.20M | 7.64M | 10.19M | 7.19M |
| Change receivables | - | -10.96M | 2.56M | -8.88M | -4.52M |
| Cash flows other operating | - | -0.63M | 3.07M | -7.39M | 0.34M |
| Cash and cash equivalents changes | - | -4.35M | 9.37M | 0.18M | 1.44M |
| Change in working capital | -21.43M | -11.72M | 23.64M | -15.98M | 0.73M |
| Stock based compensation | 7.26M | 7.87M | 7.92M | 6.99M | 5.94M |
| Other non cash items | 10.24M | 5.06M | 5.67M | -0.56M | 2.92M |
| Free cash flow | 50.29M | 68.20M | 92.36M | 52.26M | 65.81M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| USPH U.S. Physical Therapy, Inc. |
10.61 11.90% |
99.79 | 55.64 | 32.68 | 2.38 | 2.83 | 2.55 | 19.14 |
| HCA HCA Healthcare, Inc. |
3.76 0.74% |
514.46 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
2.51 0.86% |
294.76 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.17 1.18% |
14.58 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
4.81 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.
1300 West Sam Houston Parkway South, Houston, TX, United States, 77042
713 297 7000
3570
| Name | Title | Year Born |
|---|---|---|
| Mr. Christopher J. Reading | Pres, CEO & Director | 1964 |
| Mr. Carey P. Hendrickson | Chief Financial Officer | 1962 |
| Mr. Graham D. Reeve M.B.A., P.T. | Chief Operating Officer - West | 1964 |
| Mr. Eric Joseph Williams | Chief Operating Officer - East | 1966 |
| Mr. Jake Martinez | Sr. VP of Fin. & Accounting | 1979 |
| Mr. Chadd Pence | Sr. VP of Information Systems | NA |
| Mr. Richard S. Binstein | Exec. VP, Gen. Counsel & Sec. | 1961 |
| Ms. Jayne Fleck Pool ATC, PT, SCS | Sr. VP & Chief Compliance Officer | NA |
| Mr. Jason Anderson | VP of HR | NA |
| Mr. Jon C. Bates | VP & Corp. Controller | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.